About us

Pelago Bioscience was founded in 2013 with the aim to develop the patented Cellular Thermal Shift Assay (CETSA®) for maximum utility and customer value in drug discovery and diagnostics. Today, Pelago Bioscience is a Drug Discovery Research Partner supporting preclinical drug discovery and development with our expertise in biologically relevant assay systems. Our unique core technology: the Cellular Thermal Shift Assay (CETSA® by Pelago Bioscience) has multiple assay formats that make it a keystone of decision-making throughout the drug discovery pipeline. We offer a range of customized services, from confirming target engagement to strengthening target validation and understanding the mechanism of action of your compounds. Our approach is designed to help you make better decisions faster, no matter where you are in the drug discovery process.


Find out more about the Pelago services here.

Pelago Bioscience is 10 Years Old!

On February 28th, Pelago Bioscience AB has just hit its 10th year anniversary! It’s hard to believe that a decade has passed since Pelago started this incredible journey, and we couldn’t be more proud of what we’ve achieved together.

Over the past 10 years, we’ve grown from a small team with big dreams to a company with a global presence and a reputation for delivering exceptional services for better human health.

Heartfelt thanks to every single team member, past and present, for their hard work, dedication, and unwavering commitment to our shared goals. Without your passion, creativity, and expertise, we wouldn’t be where we are today.

As we celebrate this milestone, we’re excited to look ahead to the next 10 years and beyond. We have big plans for the future, and we know that together, we can achieve even more.